Resource Center
Explore Resource Types
Focused Solutions
Biologics
Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.
Cell and Gene Therapy
The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.
Disease Research
New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.
Drug Development
The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.
Functional Genomic Screening
Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies
Integrated Lab Automation
From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations
Physiological Model Solutions
Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.
Precision Medicine Research
Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.
Small Molecule Drug Discovery
With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.
All Resources
Filters
553 - 564 of 1187 Results
Reducing The Time To Diagnosis For Spinal Muscular Atrophy
Sample Collection Instructions_French
Mosaicism, De Novo Occurrence and Subclinical Parents: Lessons Learned From Two-Year ABCD1 Second-Tier Confirmatory Testing
Direct Effects of Inbreeding: Increased Burden of Rare Genetic Disorders in Indian Sub-continent
Fascioscapulohumeral Muscular Dystrophy Genetic Testing by Optic Mapping
Utility of Metabolomics Screening in Familial Hypercholesterolemia in Combination with Genetic Diagnosis
Global Approach to Prenatal Testing
Towards Implementation Whole Genome Sequencing as a First Tier Test in Genomic Testing
Testing reportedly healthy individuals for a panel of 59 medically actionably genes: are 59 genes enough?
High diagnostic yield from clinical genome sequencing supports genome sequencing as the first-tier genetic test: Evidence-based from 2100 index cases
Genetic basis of Oculopharyngeal Muscular Dystrophy: Detection of Alanine repeats in PABPN1 gene by Next Generation Sequencing
Non-Invasive Prenatal Screening by Vanadis LifeCycle® Platform
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.